JNC Corporation (Headquarters: Chiyoda-ku, Tokyo; CEO and President: Keizo Yamada) has developed a next-generation chromatography media with large diameter continuous pore structure designed for isolation and purification of inactivated viruses for vaccine manufacturing.
Please refer to the following URL for details.
https://www.jnc-corp.co.jp/fine/en/cellufine/development/contents/mlp1000.php
[Inquiries concerning this press release] General Affairs Dept., JNC CorporationPhone: +81-3-3243-6370Research & Development Division, JNC CorporationPhone: +81-436-37-2265